H.R. 5799 · 115th Congress
Medicaid DRUG Improvement Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 115th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
BlackburnSponsor3 cosponsors · 3 R
2 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act
What it does: CRS summary · Reported to House with amendment(s) · Jun 12, 2018
Medicaid Drug Review, Utilization, Good Governance Improvement Act or the Medicaid DRUG Improvement Act
This bill requires state Medicaid programs to establish drug-review and utilization requirements for enrollees, particularly with respect to opioid prescriptions. Drug use review programs must also identify prescribing or billing practices by providers that indicate abuse or excessive utilization.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Medicaid Drug Review, Utilization, Good Governance Improvement Act
Latest action (Jun 12, 2018): Placed on the Union Calendar, Calendar No. 563.
Policy area: Health · Origin: House · Introduced: May 15, 2018
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.